In a 15-12RM fibrosarcoma tumor model in which tumors show a growth-regression-recurrence pattern, IL-13 had a key role for downregulation of CTLs, and CD1d−/− mice had decreased IL-13 production and resistance to the recurrence. Here, CD1D is linked to neoplasm.